Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Multitrend Indo Tbk (BABY) vs Dharma Polimetal Tbk. (DRMA) Price & Performance

Multitrend Indo TbkTrade
Dharma Polimetal Tbk.Trade

Price performance (Past 24H)

Key statistics

Multitrend Indo Tbk vs Dharma Polimetal Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp174 (market cap 485.32B, 589.3K 24h volume), while Dharma Polimetal Tbk. trades at Rp900 (market cap 4.24T, 134.1K 24h volume). The key difference: Dharma Polimetal Tbk. is far larger — about 8.7× Multitrend Indo Tbk's market cap, and Multitrend Indo Tbk is more actively traded (589.3K versus 134.1K). Which is the better fit depends on your goals.

BABYDRMA
Market Cap
485.32B4.24T
Volume
589.3K134.1K
Lot
5.89K1.34K
Turnover
101.82M120.97M
Average Price
172.78902.07
Value
101.82M120.97M
Indicative Equilibrium Price
174900
Indicative Equilibrium Volume
604

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BABY
View details
DRMA
View details

About Multitrend Indo Tbk

PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.

Read more on BABY

About Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Read more on DRMA